Cefotaxime Suppliers & Bulk Manufacturers

Available Forms: IV and IM Injection

Available Strengths: 250 mg, 500 mg, 1 g, 2 g

Reference Brands: Claforan(US)

Category: Critical Care

Cefotaxime is a third-generation cephalosporin antibiotic used to treat severe infections like pneumonia and sepsis. Available in 250 mg to 2 g IV/IM vials, it is supplied under brands like Claforan and by major generics. Pharma B2B platforms offer bulk sourcing for hospitals and emergency care providers. Cefotaxime is available in IV and IM Injection and strengths such as 250 mg, 500 mg, 1 g, 2 g. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Cefotaxime is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Cefotaxime can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Cefotaxime is a third-generation cephalosporin antibiotic used for the treatment of severe bacterial infections such as pneumonia, sepsis, meningitis, and urinary tract infections. Administered via intravenous (IV) or intramuscular (IM) injection, it is available as a lyophilized powder in 250 mg, 500 mg, 1 g, and 2 g vials. In the US, Cefotaxime was initially marketed as Claforan by Sanofi and is now widely available as a generic from Hikma, Sagent, and others. In the EU, leading suppliers include Fresenius Kabi, Sandoz, and Mylan. Pharma B2B platforms enable efficient sourcing of bulk Cefotaxime for hospitals and critical care centers.